Outlook Therapeutics, Inc. (OTLK) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -7.83T | -14.94T | -12.38M | -11.9M | -16.58M | -10.97M | -16.98M | -19.51M | -19.27M | -13.03M | -12.74M | -13.22M | -8.11M | -8.9M | -10.25M | -21.1M | -14.33M | -10.99M | -8.99M | -20.19M |
| Operating CF Margin % | -99999900% | 99999900% | 13484.69% | -790.61% | - | - | -9982.07% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -47203077.13% | -99999900% | 27.12% | 39.01% | 13.93% | 15.84% | -33.28% | -47.64% | -137.44% | -46.41% | -24.3% | 37.36% | 43.39% | 19.01% | -14.02% | -4.49% | -22.03% | 17.52% | 25.56% | -239.05% |
| Net Income | -4.45T | -23.06T | -13.29M | -20.15M | -46.36M | 17.38M | 5.69M | 44.41M | -114.29M | -11.18M | -12.99M | -20.68M | -6.65M | -18.66M | -14.35M | -17.54M | -19.7M | -14.46M | -13.4M | -12.2M |
| Depreciation & Amortization | 30.42B | 30.07B | 29.74K | 29.41K | 29.1K | 28.8K | 28.8K | 28.67K | 28.2K | 28.2K | 11.22K | 11.19K | 11K | 10.78K | 51.47K | -51.27K | -51.09K | 50.87K | 50.67K | 48.18K |
| Stock-Based Compensation | 757.48B | 881.15B | 1.82M | 1.68M | 1.72M | 3.67M | 1.41M | 1.4M | 1.31M | 1.27M | 1.39M | 1.38M | 1.38M | 1.39M | 1.38M | 1.37M | 3.76M | 1.2M | 1.4M | 1.2M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 50.79K | -18.94K | 18.94K | 0 | 0 | 0 | -1.27M | -3.66M | 799.16K | -300.34K | 464.68K |
| Other Non-Cash Items | -4.16T | 7.21T | -2.64M | 4.35M | 33.94M | -38.94M | -28.33M | -63.57M | 94.94M | 993K | 856.49K | 2.91M | 1.35K | 1.9M | 451.69K | 1.96M | 4.56M | 507.07K | 253.67K | 248.19K |
| Working Capital Changes | 5.41M | -2.37M | 1.71M | 2.19M | -5.92M | 6.89M | 4.22M | -1.78M | -1.26M | -4.2M | -1.99M | 3.14M | -2.86M | 6.46M | 2.22M | -5.57M | 763.27K | 911.33K | 3.01M | -9.96M |
| Change in Receivables | -2.61M | 1.38M | 260.49K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 113.82K | -119.66K | 788.31K | -522.18K | -495.13K | -3.11M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 5.71M | -2.87M | 30.25K | 2.04M | -4.63M | 4.22M | 2.53M | 1.69M | 267K | -3.09M | 1.76M | 1.2M | -550.13K | 678.39K | 1.01M | -1.68M | 1.79M | 169.17K | -392.5K | -3.49M |
| Cash from Investing | 0 | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 3 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | -0% | 0% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 6.9T | 15.53T | 11.56M | 13.25M | 18.44M | 1.74M | -114.95K | 4.31M | 56.14M | -3.18K | 2.42M | 3.3M | -597.13K | 43.85M | 1.63M | -11.3M | 2.61M | 66.66M | 3.78M | 2.72M |
| Debt Issued (Net) | 0 | 0 | -2.33M | -906.98K | 189.97K | 0 | 4.27K | 0 | -1.08K | -3.18K | -3.08K | -2.98K | -2.89K | 19.78M | -5.68K | -11.6M | -308.33K | 9.59M | -19.72K | -19.23K |
| Equity Issued (Net) | 6.9M | 15.53M | 8.09M | 14.15M | 1.42M | 1.74M | -114.95K | 4.31M | 56.14M | 0 | 2.43M | 3.3M | -339.27K | 24.64M | 1.63M | 293K | 2.73M | 57.65M | 3.79M | 2.73M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 6.9T | 15.53T | 5.8M | 0 | 16.83M | 0 | -4.27K | 0 | 0 | 0 | 0 | 0 | -254.96K | -568.93K | 0 | 0 | 188.1K | -582.25K | 7.57K | 0 |
| Net Change in Cash | -929.2B | 594.34B | -817.73K | 1.34M | 1.85M | -9.22M | -17.1M | -15.2M | 36.87M | -13.04M | -10.32M | -9.92M | -8.71M | 34.94M | -8.62M | -32.4M | -11.73M | 55.67M | -5.21M | -17.48M |
| Free Cash Flow | -7.83T | -14.94T | -12.38M | -11.9M | -16.58M | -10.97M | -16.98M | -19.51M | -19.27M | -13.03M | -12.74M | -13.22M | -8.11M | -8.9M | -10.25M | -21.1M | -14.33M | -10.99M | -8.99M | -20.19M |
| FCF Margin % | -99999900% | 99999900% | 13484.69% | -790.61% | - | - | -9982.07% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -47203077.13% | -99999900% | 27.12% | 39.01% | 13.93% | 15.84% | -33.28% | -47.64% | -137.44% | -46.41% | -24.3% | 37.36% | 43.39% | 19.01% | -14.02% | -4.49% | -22.03% | 17.52% | 25.56% | -239.05% |
| FCF per Share | -95655.40 | -586389.31 | -0.49 | -0.32 | -0.54 | -0.45 | -0.92 | -0.77 | -1.35 | -1.00 | -0.98 | -1.03 | -0.63 | -0.78 | -0.97 | -1.91 | -1.31 | -1.17 | -1.07 | -2.40 |
| FCF Conversion (FCF/Net Income) | 999999.00x | 647888.96x | 0.93x | 0.59x | 0.36x | -0.63x | -2.98x | -0.44x | 0.17x | 1.17x | 0.98x | 0.64x | 1.22x | 0.48x | 0.71x | 1.20x | 0.73x | 0.76x | 0.67x | 1.66x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 475K | 0 | 1K | 0 | 0 | 1.16M | 603 | 1.53M | 1.86K | 20.16K | 28.32K | 7.42K |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |